Got a Question?
If you have a question for our guest, host or DRG please submit it here.
New look. Same commitment. Decision Resources Group becomes Clarivate. Read more here
Becoming one of the leaders in developing COVID-19 diagnostics
Guest: Mark Stevenson, Vice President and Chief Operation Officer, Thermo Fisher Scientific
In this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Mark Stevenson, Vice President and Chief Operations Officer at Thermo Fisher Scientific. Mark talks to Mike about day-to-day pandemic effects on operations and priorities, and how they have redistributed resources to help combat impact and maintain longer-term business focus. He also explores how he feels the pandemic will change supply chains moving forward, as well as the life science ecosystem in general. Mark goes on to discuss exciting new developments for his company, including their bid to acquire Qjagen, drug discovery tools and innovation across the life sciences industry. Mark explains how important it is to work with other innovators in the industry and the growing clusters of innovators to look out for across the globe. Watch the full interview to learn more.
About our Guest
Mark Stevenson, Vice President and Chief Operation Officer, Thermo Fisher Scientific
Mark Stevenson has been Executive Vice President and Chief Operating Officer of Thermo Fisher Scientific since August 2017 and has responsibility for the company’s life sciences, analytical instruments, laboratory products and specialty diagnostics businesses as well as the company’s innovation and digital strategy. He joined the company as Executive Vice President and President, Life Sciences Solutions, through the acquisition of Life Technologies in 2014.
About our Host
Mike Ward, Head of Thought Leadership, DRG
Mike Ward serves as Global Head of Thought Leadership at Decision Resources Group (DRG), part of Clarivate. As both a journalist and analyst, Mike has been writing, analyzing and commenting on the life sciences industry for more than 35 years. He has held editorial and content leadership roles at various publications and organizations across the industry.
